OptimizeRx Corporation (OPRX) earnings
OPRX earnings moved a median of -0.65% by the close. Quarterly and annual OPRX reports and results, each read against the price at its own news timestamp. Back to the OPRX overview →
34 measured OPRX earnings events.
Where these OPRX earnings landedvs 34 measured OPRX earnings reactions
| Middle 50% of OPRX earnings reactions | -5.49% to +2.28% |
|---|---|
| Median reaction (to close) | -0.65% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 OPRX earnings events with a measured close landed between -5.49% and +2.28%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | +0.97% | +0.00% | |
| OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance | Press release | +8.50% | +28.74% | |
| OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET | Press release | +1.42% | +0.47% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | -0.79% | +2.37% | |
| OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance | Press release | -10.49% | -14.07% | |
| OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET | Press release | +0.00% | +0.00% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | +0.33% | +6.49% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.37% | +2.48% | |
| OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance | Press release | -10.72% | -14.81% | |
| OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET | Press release | +0.51% | +2.89% | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | -6.57% | -6.47% | |
| OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance | Press release | +6.15% | +6.46% | |
| OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET | Press release | +2.95% | -1.82% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | +4.25% | -8.51% | |
| OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance | Press release | +2.22% | -4.26% | |
| OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET | Press release | -1.18% | -0.71% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | +0.70% | +0.82% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.99% | +0.62% | |
| OptimizeRx Reports Third Quarter 2024 Financial Results | Press release | -3.74% | -14.53% | |
| OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET | Press release | +0.18% | -4.75% | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | +0.95% | -0.60% | |
| Form NT 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form NT | -0.82% | -1.87% | |
| OptimizeRx Reports Second Quarter 2024 Financial Results | Press release | -0.28% | -5.20% | |
| OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET | Press release | +0.10% | +2.88% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -3.53% | |
| OptimizeRx Reports First Quarter 2024 Financial Results | Press release | -4.95% | -5.59% | |
| OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET | Press release | +3.05% | +6.30% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | -0.45% | -9.62% | |
| Form NT 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form NT | +3.90% | +3.14% | |
| OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET | Press release | +0.86% | +1.55% | |
| OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 | Press release | -11.02% | -7.19% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.01% | |
| OptimizeRx Reports Third Quarter 2023 Financial Results | Press release | -8.93% | -10.76% | |
| OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET | Press release | +0.00% | -4.91% |
Keep exploring
More OPRX: analyst actions → · SEC filings → · OPRX overview →
Other Technology names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rogers Corporation (ROG) | 278 | -0.10% | 42% |
| SPS Commerce, Inc. (SPSC) | 277 | 0.00% | 50% |
| MITSUBISHI ELEC UNSP/ADR (MIELY) | 275 | 0.00% | 48% |
| Evertec, Inc. (EVTC) | 274 | -0.10% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.